391.17001 USD
0.33
0.08%
Last update Dec 16, 3:59 PM EST
Post-market
Day range
388.54001
399.57001
Previous close
391.5
Open
390.64999
Access this stock data via API
Subscribe
Alnylam Pharmaceuticals Inc.
391.17
0.33
0.08%

Financials

Income statement

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 1.2B 773.7M 594.2M 593.2M
Cost of revenue 200.2M 143.0M 71.0M 102.8M
Gross profit 1.0B 630.7M 523.1M 490.3M
Operating expense
Research & development 358.8M 323.6M 265.1M 300.2M
Selling general and admin 322.1M 323.3M 239.9M 295.3M
Other operating expenses
Operating income 368.0M -16.2M 18.1M -105.2M
Non operating interest income
Income 28.7M 27.5M 28.7M 31.0M
Expense 44.4M 40.2M 38.6M 39.0M
Other income expense -113.3M -6.4M -49.7M -80.8M
Pretax income 239.0M -35.4M -41.6M -194.0M
Tax provision -12.1M 30.9M 15.9M -110.2M
Net income 251.1M -66.3M -57.5M -83.8M
Basic EPS 1.9 -0.5 -0.4
Diluted EPS 1.8 -0.5 -0.4
Basic average shares 131.4M 130.6M 129.7M
Diluted average shares 137.3M 130.6M 129.7M
EBITDA 401.0M 35.4M 71.3M -84.6M
Net income from continuing op. 251.1M -66.3M -57.5M -83.8M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Post-market

Exchange is currently open for post-market.
Post market session closes in 1 hour 27 minutes

18:33
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).